BRIEF published on 05/30/2024 at 07:35, 5 months 22 days ago Ikonisys lance un nouveau site Web pour promouvoir la technologie FISH et l'automatisation totale des soins de santé Automatisation Soins De Santé Ikonisys Technologie POISSON Dépistage De Masse
BRIEF published on 05/30/2024 at 07:35, 5 months 22 days ago Ikonisys Launches New Website to Promote FISH Technology and Total Automation in Healthcare Automation Healthcare Ikonisys FISH Technology Mass Screening
PRESS RELEASE published on 05/30/2024 at 07:30, 5 months 22 days ago Inside Information / Other news releases Ikonisys launches new website focusing on FISH technology and total automation in healthcare, enhancing mass cancer screening with advanced solutions and seamless integration Healthcare Ikonisys FISH Technology Mass Screening Total Automation
BRIEF published on 05/15/2024 at 07:35, 6 months 6 days ago Ikonisys: New international patent for Hospitex Ikonisys BLOCKfast Hospitalex International International Patent Cancer Diagnosis
BRIEF published on 05/15/2024 at 07:35, 6 months 6 days ago Ikonisys : Nouveau brevet international pour Hospitex Ikonisys Hospitex International BLOCKfast Brevet International Diagnostic Du Cancer
PRESS RELEASE published on 05/15/2024 at 07:30, 6 months 6 days ago Inside Information / Other news releases Hospitex International obtains international patent for BLOCKfast cyto-inclusion kit, enhancing global cancer diagnosis solutions. Company offers innovative diagnostics solutions in cytology Hospitex International BLOCKfast Cyto-inclusion Kit Global Commercial Development Cancer Diagnosis Solutions Cytology Diagnostics
PRESS RELEASE published on 05/15/2024 at 07:30, 6 months 6 days ago Informations privilégiées / Autres communiqués Hospitex obtient un brevet international pour kit cytoinclusion BLOCKfast, produit phare utile en anatomie pathologique, ouvrant perspectives de développement commercial mondial Hospitex Développement Commercial BLOCKfast Brevet International Diagnostic Cancer
PRESS RELEASE published on 02/06/2024 at 10:11, 9 months 15 days ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy Ikonisys SA receives Buy recommendation and increased price target to EUR 6.30 from EUR 4.50 per share after acquiring Hospitex, an Italian-based cytology company Acquisition Strategic Partnership Ikonisys SA Hospitex Cancer Diagnostics
PRESS RELEASE published on 11/01/2023 at 11:26, 1 year ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy
PRESS RELEASE published on 07/31/2023 at 07:56, 1 year 3 months ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy
Published on 11/21/2024 at 14:15, 24 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 39 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 39 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 39 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 23 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 24 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 13:41, 58 minutes ago Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Published on 11/21/2024 at 06:58, 7 hours 41 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 7 hours 41 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 7 hours 41 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 18 hours 32 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 19 hours 19 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
